. Author manuscript; available in PMC: 2020 Apr 29.

Published in final edited form as: J Neuroimmune Pharmacol. 2018 Oct 1;13(4):532–540. doi: 10.1007/s11481-018-9811-8

Table 2.

LASSO regression selected tPGSs

	Estimate	Std.Err	Z.Value	Pr(>\|Z\|)

SCZ_1e-3	104.20	14.91	6.99	2.74E-12
ANO	−6.97	2.05	−3.40	0.0007
BIP	65.74	11.53	5.70	1.20E-08
BMI	−442.61	121.83	−3.63	0.0003
CAN	36.86	12.21	3.02	0.0026
earlyLate	7.09	4.24	1.67	0.0944
MEM	1265.04	192.06	6.59	4.50E-11
BIP.II	623.61	30.20	20.65	< 2.00E-16
OPEN	35.62	8.72	4.08	4.42E-05
OPPH	−895.13	157.70	−5.68	1.38E-08
SWB	−997.20	169.64	−5.88	4.15E-09
VNR	−391.85	99.71	−3.93	8.49E-05
YoS	904.81	193.99	4.66	3.10E-06

Abbreviations: SCZ, schizophrenia; ANO, anorexia; BIP, bipolar disorder; BMI, body mass index; CAN, cannabis dependence; earlyLate, early person vs late person; MEM, working memory; BIP.II, bipolar disorder, GWAS II; OPEN, neo openness; SWB, subjective wellbeing; VNR, verbal and numeric reasoning; YoS, years of schooling.